Drug induced regulation of SHC1 levels may offer a novel therapeutic approach for kidney disease treatment by reducing oxidative stress70, a hypothesis which prompted, as a first step, the investigation of SHC1 expression in the IgAN kidney tissue. Here, SHC1 is linked to kidney disorder.